Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-25 @ 12:43 AM
NCT ID:
NCT00785967
Eligibility Criteria:
Inclusion Criteria:
1. HIV-1 infected males, as determined by ELISA and Western blot;
2. \>18 years of age;
3. Current ARV therapy with efavirenz + Truvada® for \>52 weeks;
4. HIV-1 RNA (bDNA) \<50 copies/ml for at least 52 weeks;
5. No history of hepatitis A vaccine, and HAV antibody negative.
Exclusion Criteria:
1. any immunomodulatory therapy within 24 weeks of screening or during the trial;
2. any type of vaccine within 24 weeks of screening or during the trial;
3. current opportunistic infection, malignancy, acute infection, or febrile illness;
4. history of hypersensitivity to a vaccine, components of a vaccine, or components of a vaccine container.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT00785967
Study Brief:
Protocol Section:
NCT00785967